Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
Cardiovascular Disease Information Center
USPSTF Urges Behavioral Counseling for Those With CVD Risk
The US Preventive Services Task Force (USPSTF) recommends behavioral counseling to promote a healthy lifestyle for adults at risk for cardiovascular disease.
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
Angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker use is not associated with COVID-19 test positivity.
Teen Obesity, T2DM, Hypertension May Lead to Early Vascular Aging
The presence of obesity, type 2 diabetes, and elevated systolic blood pressure (SBP) in adolescence accelerates the progression of risk factors that play a role in the development of early vascular aging.
Premature Mortality Rates Up for CAD in Women From Rural US
Coronary artery disease mortality rates have increased among women from rural areas, while social determinants of health increase the risk for 90-day mortality after heart failure hospitalization.
Hypertension, Obesity, Diabetes Common in US COVID-19 Patients
The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension, obesity, and diabetes.
Interim AHA Guidelines for Reducing COVID-19 Transmission During Resuscitation in Pediatric Care
The American Heart Association and the American Academy of Pediatrics have released interim guidance for resuscitation care for pediatric patients with known or suspected COVID-19.
ACEI/ARB Treatment May Benefit Patients With COVID-19 and Hypertension
Treatment of patients with hypertension who are infected with the severe acute respiratory syndrome coronavirus 2 with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers may improve clinical outcomes.
Joint Statement Issued on Reducing Arrhythmia Risk With COVID-19 Repurposed Drugs
Although not approved by the Food and Drug Administration (FDA) for COVID-19, hydroxychloroquine and azithromycin have been gaining momentum as potential treatments based on results of small studies.
Time to Telemedicine Diagnosis Useful to Evaluate Effectiveness of Telemedicine in AMI
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
Rural Doctors Can Be Trained to Treat Advanced Heart Failure
Rates of death, pump thromboses, infections higher for patients who do not receive LVAD-specific care
Wearable Technologies, the Future of Cardiovascular Care?
Wearable technologies that include digital and automated health, as well as telehealth, are expected to be well integrated into cardiovascular care in the next 5 years.
FDA Approves 50cc Total Artificial Heart System as Bridge to Transplantation
The Food and Drug Administration approved the 50cc temporary Total Artificial Heart System developed and manufactured by SynCardia Systems, LLC as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
Integrating ECG Technology Into Your Practice and Your Network Considerations for Efficiently Connecting ECG Solutions to Your EMR
Have you thought about the best way to integrate electrocardiogram technology into your practice?
Joint Statement Issued Addressing Concerns Over COVID-19 and ACE Inhibitor, ARB Use
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.
National Dietary Guideline Adherence Lowers Cardiovascular Risk
2015 to 2020 Dietary Guidelines for Americans performed similar to other dietary indices.
Psoriasis in Adolescents Linked to Cardiometabolic Risk Factors
Early markers of cardiovascular and metabolic disease were elevated in adolescents with psoriasis, despite early disease.
Multiple Sclerosis Outcomes Worsened When Youths Transition to Adult Care
Roughly half of patients with pediatric-onset multiple sclerosis (MS) who transition to adult clinics experience worsened clinical disability.
Moderate Egg Consumption Not Linked to CVD Risk Overall
Findings based on data from 3 cohorts and updated meta-analysis of prospective cohort studies.
Pharmacologic and Electrical Cardioversion Both Found to Be Effective for Acute AF
Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent onset acute atrial fibrillation.
Want to read more?
Please login or register first to view this content.
Next post in Cardiovascular Disease Information Center
